Castlight Health Inc (NYSE:CSLT) CEO John C. Doyle sold 18,519 shares of the stock in a transaction that occurred on Monday, November 19th. The shares were sold at an average price of $2.69, for a total transaction of $49,816.11. Following the sale, the chief executive officer now directly owns 268,523 shares of the company’s stock, valued at approximately $722,326.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Castlight Health stock traded up $0.02 during mid-day trading on Tuesday, reaching $2.75. 513,100 shares of the company traded hands, compared to its average volume of 553,196. The company has a current ratio of 1.89, a quick ratio of 1.89 and a debt-to-equity ratio of 0.02. Castlight Health Inc has a fifty-two week low of $2.20 and a fifty-two week high of $5.95. The firm has a market capitalization of $388.44 million, a price-to-earnings ratio of -10.58 and a beta of 1.09.

Castlight Health (NYSE:CSLT) last issued its quarterly earnings results on Tuesday, November 6th. The software maker reported ($0.01) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.06. Castlight Health had a negative net margin of 29.23% and a negative return on equity of 16.59%. The business had revenue of $40.04 million for the quarter, compared to analyst estimates of $38.11 million. During the same quarter in the prior year, the business posted ($0.05) EPS. Castlight Health’s revenue for the quarter was up 16.1% compared to the same quarter last year. On average, sell-side analysts predict that Castlight Health Inc will post -0.23 EPS for the current fiscal year.

A number of research analysts have issued reports on CSLT shares. Chardan Capital lowered shares of Castlight Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $6.00 to $4.80 in a research note on Tuesday, July 31st. Dougherty & Co upped their price target on shares of Castlight Health from $6.00 to $7.00 and gave the company a “buy” rating in a research note on Monday, July 23rd. Cantor Fitzgerald restated a “buy” rating and set a $5.00 price target on shares of Castlight Health in a research note on Friday, August 17th. Canaccord Genuity cut their price target on shares of Castlight Health from $7.00 to $6.00 and set a “buy” rating on the stock in a research note on Tuesday, July 31st. Finally, ValuEngine lowered shares of Castlight Health from a “buy” rating to a “hold” rating in a research note on Monday, July 30th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. Castlight Health has an average rating of “Buy” and a consensus price target of $4.81.

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. increased its stake in shares of Castlight Health by 30.4% in the second quarter. BlackRock Inc. now owns 4,637,348 shares of the software maker’s stock worth $19,710,000 after acquiring an additional 1,081,140 shares during the period. Dimensional Fund Advisors LP increased its stake in shares of Castlight Health by 93.8% in the second quarter. Dimensional Fund Advisors LP now owns 263,904 shares of the software maker’s stock worth $1,122,000 after acquiring an additional 127,761 shares during the period. FMR LLC increased its stake in shares of Castlight Health by 2.1% in the second quarter. FMR LLC now owns 12,620,881 shares of the software maker’s stock worth $53,639,000 after acquiring an additional 254,616 shares during the period. GMT Capital Corp acquired a new stake in shares of Castlight Health in the second quarter worth $2,990,000. Finally, Russell Investments Group Ltd. acquired a new stake in shares of Castlight Health in the second quarter worth $2,315,000. Hedge funds and other institutional investors own 53.41% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “John C. Doyle Sells 18,519 Shares of Castlight Health Inc (CSLT) Stock” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/11/20/john-c-doyle-sells-18519-shares-of-castlight-health-inc-cslt-stock.html.

Castlight Health Company Profile

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers communication and testing, implementation, and user customer support services.

Featured Story: How to calculate compound interest

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.